238 related articles for article (PubMed ID: 15489387)
1. The beneficial antispasticity effect of botulinum toxin type A is maintained after repeated treatment cycles.
Bakheit AM; Fedorova NV; Skoromets AA; Timerbaeva SL; Bhakta BB; Coxon L
J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1558-61. PubMed ID: 15489387
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke.
Bakheit AM; Pittock S; Moore AP; Wurker M; Otto S; Erbguth F; Coxon L
Eur J Neurol; 2001 Nov; 8(6):559-65. PubMed ID: 11784339
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
Kaňovský P; Slawek J; Denes Z; Platz T; Comes G; Grafe S; Pulte I
J Rehabil Med; 2011 May; 43(6):486-92. PubMed ID: 21533328
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke.
Bakheit AM; Thilmann AF; Ward AB; Poewe W; Wissel J; Muller J; Benecke R; Collin C; Muller F; Ward CD; Neumann C
Stroke; 2000 Oct; 31(10):2402-6. PubMed ID: 11022071
[TBL] [Abstract][Full Text] [Related]
5. Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study.
Sun SF; Hsu CW; Sun HP; Hwang CW; Yang CL; Wang JL
Neurorehabil Neural Repair; 2010 Jan; 24(1):34-41. PubMed ID: 19729582
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
Slawek J; Bogucki A; Reclawowicz D
Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
[TBL] [Abstract][Full Text] [Related]
7. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
[TBL] [Abstract][Full Text] [Related]
8. Effects of repeated abobotulinumtoxinA injections in upper limb spasticity.
Gracies JM; O'Dell M; Vecchio M; Hedera P; Kocer S; Rudzinska-Bar M; Rubin B; Timerbaeva SL; Lusakowska A; Boyer FC; Grandoulier AS; Vilain C; Picaut P;
Muscle Nerve; 2018 Feb; 57(2):245-254. PubMed ID: 28590525
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.
Rosales RL; Kong KH; Goh KJ; Kumthornthip W; Mok VC; Delgado-De Los Santos MM; Chua KS; Abdullah SJ; Zakine B; Maisonobe P; Magis A; Wong KS
Neurorehabil Neural Repair; 2012 Sep; 26(7):812-21. PubMed ID: 22371239
[TBL] [Abstract][Full Text] [Related]
10. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type A in post-stroke upper limb spasticity.
Kaji R; Osako Y; Suyama K; Maeda T; Uechi Y; Iwasaki M;
Curr Med Res Opin; 2010 Aug; 26(8):1983-92. PubMed ID: 20569068
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of botulinum toxin A in upper limb function of hemiplegic patients.
Rousseaux M; Kozlowski O; Froger J
J Neurol; 2002 Jan; 249(1):76-84. PubMed ID: 11954872
[TBL] [Abstract][Full Text] [Related]
13. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
Brashear A; Gordon MF; Elovic E; Kassicieh VD; Marciniak C; Do M; Lee CH; Jenkins S; Turkel C;
N Engl J Med; 2002 Aug; 347(6):395-400. PubMed ID: 12167681
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study.
Santamato A; Micello MF; Panza F; Fortunato F; Pilotto A; Giustini A; Testa A; Fiore P; Ranieri M; Spidalieri R
Eur J Phys Rehabil Med; 2013 Aug; 49(4):483-9. PubMed ID: 23480980
[TBL] [Abstract][Full Text] [Related]
15. High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis.
Baricich A; Grana E; Carda S; Santamato A; Cisari C; Invernizzi M
J Neural Transm (Vienna); 2015 Sep; 122(9):1283-7. PubMed ID: 25724294
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial.
Hesse S; Reiter F; Konrad M; Jahnke MT
Clin Rehabil; 1998 Oct; 12(5):381-8. PubMed ID: 9796928
[TBL] [Abstract][Full Text] [Related]
17. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke.
Pittock SJ; Moore AP; Hardiman O; Ehler E; Kovac M; Bojakowski J; Al Khawaja I; Brozman M; Kanovský P; Skorometz A; Slawek J; Reichel G; Stenner A; Timerbaeva S; Stelmasiak Z; Zifko UA; Bhakta B; Coxon E
Cerebrovasc Dis; 2003; 15(4):289-300. PubMed ID: 12686794
[TBL] [Abstract][Full Text] [Related]
18. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study.
Hyman N; Barnes M; Bhakta B; Cozens A; Bakheit M; Kreczy-Kleedorfer B; Poewe W; Wissel J; Bain P; Glickman S; Sayer A; Richardson A; Dott C
J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):707-12. PubMed ID: 10811692
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity: results of the German-Austrian open-label post-marketing surveillance prospective study.
Jost WH; Hefter H; Reissig A; Kollewe K; Wissel J
J Neurol Sci; 2014 Feb; 337(1-2):86-90. PubMed ID: 24361062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
